The release of substance P from cultured dorsal root ganglion neurons requires the non-neuronal cells around these neurons

Journal of Pharmacological Sciences

Volumn 105, Issue 3, 2007, Pages 264-271

  Tang, He Bin ^a   Li, Yu Sang ^b   Nakata, Yoshihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Capsaicin; Dorsal root ganglion (DRG) neuron; Non neuronal cell; Substance P content; Substance P release

Indexed keywords

CAPSAICIN; POTASSIUM CHLORIDE; SUBSTANCE P;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; SPINAL GANGLION;

EID: 36348951624     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071359     Document Type: Article

References (39)

1. Ai X, MacPhedran SE, Hall AK. Depolarization stimulates initial calcitonin gene-related peptide expression by embryonic sensory neurons in vitro. J Neurosci. 1998;18:9294-9302.
2. Tang HB, Inoue A, Hide I, Hirate K, Nakata Y. Effects of zaltoprofen on bradykinin-induced responses in primary afferent neurons. J Pharmacol Sci. 2003;91 Suppl 1:120P.
3. Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci. 2001;14:1091-1104.
4. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev. 2002;54:285-322.
5. Purkiss J, Welch M, Doward S, Foster K. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol. 2000;59:1403-1406.
6. Oshita K, Inoue A, Tang HB, Nakata Y, Kawamoto M, Yuge O. CB1 cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P release in cultured rat dorsal root ganglion cells. J Pharmacol Sci. 2005;9:377-385.
7. Tang HB, Inoue A, Oshita K, Hirate K, Nakata Y. Zaltoprofen inhibits bradykinin-induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells. Neuropharmacology. 2005;48:1035-1042.
8. Tang HB, Inoue A, Iwasa M, Hide I, Nakata Y. Substance P release evoked by capsaicin or potassium from rat cultured dorsal root ganglion neurons is conversely modulated with bradykinin. J Neurochem. 2006;97:1412-1418.
9. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem. 1999;73:2206-2213.
10. Brechenmacher C, Larmet Y, Feltz P, Rodeau JL. Cultured rat sensory neurones express functional tachykinin receptor subtypes 1, 2 and 3. Neurosci Lett. 1998;241:159-162.
11. Snider RM, Constantine JW, Lowe JA 3rd, Longo KP, Lebel WS, Woody HA, et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991;251:435-437.
12. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev. 1993;73:229-308.
13. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 1998;392:390-394.
14. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 1998;281:1640-1645.
15. Grady EF, Yoshimi SK, Maa J, Valeroso D, Vartanian RK, Rahim S, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000;130:505-512.
16. Otten U, Lorez HP, Businger F. Nerve growth factor antagonizes the neurotoxic action of capsaicin on primary sensory neurones. Nature. 1983;301:515-517.
17. Igwe OJ. c-Src kinase activation regulates preprotachykinin gene expression and substance P secretion in rat sensory ganglia. Eur J Neurosci. 2003;18:1719-1730.
18. Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science. 2002;298:556-562.
19. Tang HB, Inoue A, Oshita K, Nakata Y. Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons. Eur J Pharmacol. 2004;498:37-43.
20. Tang HB, Nakata Y. Olopatadine attenuates the enhancement of capsaicin-evoked substance P release by bradykinin from cultured dorsal root ganglion neurons. Eur J Pharmacol. 2006;552:78-82.
21. Sango K, Horie H, Sotelo JR, Takenaka T. A high glucose environment improves surival of diabetic neurons in culture. Neurosci Lett. 1991;129:277-280.
22. Keller EA, Zamparini A, Borodinsky LN, Gravielle MC, Fiszman ML. Role of allopregnanolone on cerebellar granule cells neurogenesis. Brain Res Dev Brain Res. 2004;153:13-17.
23. Hong JS, Costa E, Yang HY. Effects of habenular lesions on the substance P content of various brain regions. Brain Res. 1976;118:523-525.
24. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci. 1988;8:2394-2405.
25. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
26. Garland A, Necheles J, White SR, Neeley SP, Leff AR, Carson SS, et al. Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. Am J Physiol. 1997;273:L1096-L1102.
27. Vedder H, Otten U. Biosynthesis and release of tachykinins from rat sensory neurons in culture. J Neurosci Res. 1991;30:288-299.
28. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med. 1999;5:117-122.
29. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24:450-455.
30. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003;2:973-985.
31. Campana WM. Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun. 2007;21:522-527.
32. Feng Z, Ko CP. Neuronal glia interactions at the vertebrate neuromuscular junction. Curr Opin Pharmacol. 2007;7:316-324.
33. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82:981-1011.
34. Jahromi BS, Robitaille R, Charlton MP. Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron. 1992;8:1069-1077.
35. Robitaille R. Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction. Neuron. 1998;21:847-855.
36. 2+ and short-term synaptic plasticity. Nature. 1994;371:603-606.
37. Waterman SA. Voltage-gated calcium channels in autonomic neuroeffector transmission. Prog Neurobiol. 2000;60:181-210.
38. Kopp UC, Cicha MZ. PGE2 increases substance P release from renal pelvic sensory nerves via activation of N-type calcium channels. Am J Physiol. 1999;276:1241-1248.
39. Cao G, Ko CP. Schwann cell-derived factors modulate synaptic activities at developing neuromuscular synapses. J Neurosci. 2007;27:6712-6722.